Gates Foundation gives $220 mln for TB research

March 15, 2012
Microsoft billionaire Bill Gates and his wife are to give $220 million over five years to the non-profit biotech firm Aeras to develop vaccines to fight tuberculosis, a company statement said Thursday.

Microsoft billionaire Bill Gates and his wife are to give $220 million over five years to the non-profit biotech firm Aeras to develop vaccines to fight tuberculosis, a company statement said Thursday.

The Bill and Melinda Gates Foundation is donating the money to Aeras which from its bases in the United States and South Africa has developed six possible TB vaccines that are being tested across Africa, Asia, Europe and America.

"This infusion of funding must be seen as a global call to action in response to one of the world's deadliest diseases," said Jim Connolly, Aeras's president and chief executive, expressing gratitude for the massive grant.

"It will allow Aeras to expand upon existing partnerships in Europe, Africa, China, and around the world."

A total of 8.8 million people globally fell ill with the contagious in 2010 and around 1.4 million died, according to the (WHO).

Trevor Mundel, president of the global health program at the , said the development of successful vaccines "would be the single greatest advance in the global fight against TB."

Once known as "consumption" for the slow wasting away of the people who died of it, one out of every three people is thought to be infected by the airborne TB organism, though only a fraction go on to develop the disease.

The WHO estimates the global of TB is $12 billion a year, with India and China together accounting for more than half that cost.

Explore further: Vaccine targeting latent TB enters clinical testing

Related Stories

Vaccine targeting latent TB enters clinical testing

December 1, 2011

Statens Serum Institut and Aeras today announce the initiation of the first Phase I clinical trial of a new candidate TB vaccine designed to protect people latently infected with TB from developing active TB disease. The ...

Recommended for you

Molecular Zika study finds possible target for tests, drugs

April 19, 2016

The molecular structure of the Zika virus as seen on x-ray crystallography revealed electrostatic differences in a key protein compared with other flaviviruses that might explain how it infects human cells, according to a ...

Zika virus may now be tied to another brain disease

April 10, 2016

The Zika virus may be associated with an autoimmune disorder that attacks the brain's myelin similar to multiple sclerosis, according to a small study that is being released today and will be presented at the American Academy ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.